Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2005 | 12-2004 | |
| Sales | 5,003 | 2,274 | 944 | 430 | 1,517 |
| Gross Profit | 5,003 | 2,274 | 944 | 430 | 1,517 |
| Operating Expenses | 5,056 | 12,192 | 14,217 | 10,944 | 9,121 |
| Operating Income | -53 | -9,918 | -13,273 | -10,515 | -7,605 |
| Interest Expense | 2 | 26 | 61 | N/A | N/A |
| Other Income | 28 | -5,414 | 1,181 | 2,224 | 1,911 |
| Pre-tax Income | -27 | -15,358 | -12,153 | -8,291 | -5,694 |
| Income Tax | 0 | 61 | 0 | 18 | -5,694 |
| Net Income Continuous | -27 | -15,419 | -12,153 | -8,308 | -5,694 |
| Minority Interests | 126 | N/A | N/A | N/A | N/A |
| Net Income | $100 | $-15,419 | $-12,153 | $-8,308 | $-5,694 |
| EPS Basic Total Ops | 0.01 | -1.21 | -1.60 | -1.50 | -2.47 |
| EPS Basic Continuous Ops | 0.01 | -1.21 | -1.60 | -1.50 | -2.47 |
| EPS Diluted Total Ops | 0.01 | -1.21 | -1.60 | -1.50 | -2.47 |
| EPS Diluted Continuous Ops | 0.01 | -1.21 | -1.60 | -1.50 | -2.47 |
| EBITDA(a) | $482 | $-14,211 | $-11,202 | $-9,695 | $-6,576 |